DISHMAN CARBOGEN AMCIS
Back to Balance Sheet
|
DISHMAN CARBOGEN AMCIS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-0.56 Cr | ₹29 Cr | ₹61 Cr | ₹125 Cr | ₹182 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of DISHMAN CARBOGEN AMCIS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-0.56 Cr |
| Mar2024 | ₹29 Cr |
| Mar2023 | ₹61 Cr |
| Mar2022 | ₹125 Cr |
| Mar2021 | ₹182 Cr |
How is Deferred Tax Assets / Liabilities of DISHMAN CARBOGEN AMCIS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.56 Cr | Negative | |
| Mar2024 | ₹29 Cr | -53.14 | |
| Mar2023 | ₹61 Cr | -51.39 | |
| Mar2022 | ₹125 Cr | -30.97 | |
| Mar2021 | ₹182 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of DISHMAN CARBOGEN AMCIS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DISHMAN CARBOGEN AMCIS | ₹2,951.0 Cr | 4.9% | 7.4% | -28.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,408.0 Cr | 1.8% | 6.8% | 17.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹206,906.0 Cr | 6.7% | 18.5% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,521.0 Cr | -3.7% | 5.5% | 39.8% | Stock Analytics | |
| CIPLA | ₹119,032.0 Cr | 5.7% | 0.6% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.1 Cr | -2% | -15.8% | -8.4% | Stock Analytics | |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DISHMAN CARBOGEN AMCIS | 4.9% |
7.4% |
-28.5% |
| SENSEX | 1.2% |
1.2% |
-5.5% |
You may also like the below Video Courses